Comprehensive Care – Why? and What? The doctor’s perspective

 

From Prof. Dr. Bernd Pohlmann, Halifax, Canada

 

Berlin (20. September 2008) – Epilepsy (= repeated unprovoked seizures) is a frequent neurological disorder with a world-wide prevalence of 0.5 to 0.8%. Epilepsy affects a human being in all dimensions. At the same time, even in the 21st century societies seem not to be prepared to deal with this disease leading to sudden unexpected “non-functioning” and occasionally frightening appearance. Despite enormous advances both in medical treatment and new techniques such as epilepsy surgery and stimulation procedures, 1/3 of all epilepsy patients remain refractory with all somatic and psychosocial sequel. They suffer frequently from psychiatric comorbidities (anxiety and depression) and significant stigmatisation. Unemployment and mortality rates are 2-3 times higher than in the general population. These facts translate into a significant public health and economic perspective. „Indirect costs“ due to comorbidity, loss of productivity, repeated counselling due to uncertainty, and unemployment account for 70% of all related health care costs. According to the most recent WHO report, epilepsy ranks 3rd within neuropsychiatric diseases (after cerebrovascular diseases and dementia) with regard to the amount of cumulated DALYs („disability-adjusted life years“).


 

Epilepsy care restricting to antiepileptic drugs and epilepsy surgery is too reductionistic to address this complex disease. Comprehensive epilepsy care (CEC) as a more holistic concept seems to be the appropriate answer to this: It “means to treat an affected individual as an integral human being with all his needs, impairments, wishes and potential within his social and professional environment… it links intervention in the narrower medical sense (AED, surgery) with non-medical intervention e.g. counselling, offering information, psychosocial assistance, rehabilitation…“ (Comprehensive Care for people with epilepsy, Libbey London-Paris 2001)

 

Comprehensive epilepsy care is not restricted to specific subgroups of epilepsies and therefore is as important for new-onset epilepsy, as for patients who are seizure-free, drug-refractory, or have significant comorbidities. It applies for all age groups.

 

The primary goals of CEC are to provide individually tailored treatment lines, to create self-awareness and coping strategies within the affected individual and finally to improve short and long-term quality of life. Prevention is the ultimative goal of CEC. Epilepsy centres as organized in the European Association of Epilepsy Centre (EAEC) are constantly striving for the best epilepsy care following the CEC concept. They try to realize this using a wide range of structures (outpatient services, short-term ward, long-term ward, long-term residential units, schools, vocational training centres, etc.) organized in a network. On an operational level they often have key components  such as 1) multidisciplinary teams, 2) frequent case conferences, 3) validated instruments and clinical pathways, 4) continuous evaluation and education, and 5) in some bigger centres accompanying research as quality standard.

 

Typical treatment domains beside standardized drug and surgical therapy are psychiatric treatment, diagnosis of pseudoseizure, coping strategies for emotional disturbances, and neuropsychological problems, non-medical treatment, vocational assessment and rehabilitation, self-educational program, and specific units for people with learning disabilities.

 

Currently the described epilepsy centres seem to be without any alternatives within the available health care systems. They represent models of holistic medicine which show life-long commitment to individuals and their families. Now, they are challenged to clearly position within a cost-effectiveness driven health care system and come up with an own poignant profile. Sophisticated documentation of all treatment steps and outcome-orientated research seem crucial to this approach. Innovative concepts such as “First seizure clinics” following a strict CEC strategy (from the very beginning) may be promising undertakings in this exciting process of redefining the role of epilepsy centres.

 

Pohlmann_1

 

Slide 1: Burden of disease.

 

 

Pohlmann_2

 

Slide 2: Comprehensive Epilepsy Care.

 

 

Pohlmann_3

 

Slide 3: Comprehensive Care.

 

 

 


 

Source: 8th European Congress on Epiteptology, Satellite Symposium: “Comprehensive Care of Epilepsy in Europe”, Berlin, 20. September 2008 (Medizin und PR Kommunikation).

MEDICAL NEWS

Fitness watches generate useful information, but increase patient anxiety
A new device provides added protection against COVID-19 during endoscopic…
81 million Americans lacking space or bathrooms to follow COVID…
Front-line physicians stressed and anxious at work and home
EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19…

SCHMERZ PAINCARE

Krankenhäuser und Praxen müssen sich bei der Schmerztherapie nach Operationen…
Morbus Fabry mittels Datenanalysen aus dem PraxisRegister Schmerz aufspüren
Neandertaler besaßen niedrigere Schmerzschwelle
Deutscher Schmerz- und Palliativtag 2020 – ONLINE
Deutsche Gesellschaft für Schmerzmedizin fordert Anerkennung von Nicht-Psychologen in der…

DIABETES

„Körperstolz“: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen
Fastenmonat Ramadan: Alte und neue Herausforderung für chronisch Erkrankte während…
Sanofi setzt sich für die Bedürfnisse von Menschen mit Diabetes…

ERNÄHRUNG

Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Fast Food, Bio-Lebensmittel, Energydrinks: neue Daten zum Ernährungsverhalten in Deutschland
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf

ONKOLOGIE

Bestmögliche Versorgungssicherheit bei der Krebstherapie mit CAR-T-Zellen
Darolutamid bei Prostatakarzinom: Hinweis auf beträchtlichen Zusatznutzen
Multiples Myelom: Wissenschaftler überprüfen den Stellenwert der Blutstammzelltransplantation
Neues zur onkologischen Supportiv- und Misteltherapie und aktuelle Kongress-Highlights zum…
Neue Darreichungsform zur Antiemese bei Chemotherapie: Akynzeo® ist ab sofort…

MULTIPLE SKLEROSE

Geschützt: Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Bristol Myers Squibb erhält Zulassung der Europäischen Kommission für Ozanimod…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen

PARKINSON

Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Putzfimmel im Gehirn
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…